Glutathione S-transferase polymorphism interactions with smoking status and HPV infection in cervical cancer risk: An evidence-based meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhen, Shuai ^a,b   Hu, Chen Ming ^b   Bian, Li Hong ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER RISK; CARCINOGENESIS; CHINESE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ETHNICITY; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INDIAN; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTION; PROTEIN FUNCTION; SMOKING; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; ETHNIC GROUPS; EVIDENCE-BASED MEDICINE; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 84896738919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083497     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 74-108. (Pubitemid 40372904)
2. Zeller JL, Lynm C, Glass RM, JAMA patient page (2007) Carcinoma of the cervix. JAMA 298:2336. (Pubitemid 350146241)
3. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, et al. (2000) Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82: 1332-1228.
4. Slattery ML, Robison LM, Schuman KL, French TK, Abbott TM, et al. (1989) Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 261: 1593-1598. (Pubitemid 19072230)
5. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non-smokers. J Natl Cancer Inst 89:868-73. (Pubitemid 27268452)
6. Hengstler JG, Arand M, Herrero ME, Oesch F (1998) Polymorphisms of N-acetytransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154: 47-85.
7. Miller MC, Mohrenweiser HW, Bell DA (2001) Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120: 269-80. (Pubitemid 32375093)
8. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
9. Agodi A, Barchitta M, Cipresso R, Marzagalli R, La Rosa N, et al. (2010) Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer 20(1): 141-146.
10. Agorastos T, Papadopoulos N, Lambropoulos AF, Chrisafi S, Mikos T, et al. (2007) Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women. Eur J Cancer Prev 16: 498-504. (Pubitemid 350307498)
11. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
13. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536.
14. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49: 1-6. (Pubitemid 36078546)
15. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. (Pubitemid 34746062)
16. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7; 177-188. (Pubitemid 17189972)
17. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
18. Agodi A, Barchitta M, Cipresso R, Marzagalli R, La Rosa N, et al. (2010) Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. International Journal of Gynecological Cancer 20: 141-146.
19. Agorastos T, Papadopoulos N, Lambropoulos AF, Chrisafi S, Mikos T, et al. (2007) Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women. Eur J Cancer Prev 16: 498-504. (Pubitemid 350307498)
20. De Carvalho CR, da Silva ID, Pereira JS, de Souza NC, Focchi GR, et al. (2008) Polymorphisms of p53, GSTM1 and GSTT1, and HPV in uterine cervix adenocarcinoma. Eur J Gynaecol Oncol 29: 590-593.
21. Goodman MT, McDuffie K, Hernandez B, Bertram CC, Wilkens LR, et al. (2001) CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in multiethnic population. Gynecol Oncol 81: 263-269. (Pubitemid 32424172)
22. Huang YK, Hsieh HC, Sun JA, Chao CF, Huang RL, et al. (2006) Genetic polymorphisms of phase I and phase II xenobiotic enzymes in human papillomavirus related lesion and cancer of the uterine cervix. Tzu Chi Medical Journal 18: 267-27+328.
23. Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, et al. (2006) Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 101: 411-417. (Pubitemid 43729981)
24. Kim JW, Lee CG, Park YG, Kim KS, Kim IK, et al. (2000) Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88: 2082-2091. (Pubitemid 30233210)
25. Kiran B, Karkucak M, Ozan H, Yakut T, Ozerkan K, et al. (2010) GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol 21: 169-73.
26. Lee SA, Kim JW, Roh JW, Choi JY, Lee KM, et al. (2004) Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol 93: 14-18. (Pubitemid 38429543)
27. Liu Y, Ma W, Liu Q, Yang T, Xu X, et al. (2009) Association between genetic polymorphism of GSTM1, CYP2E1 and susceptibility to cervical cancer and its precancerous lesions in Uighur women in Xinjiang. Prog Obstet Gynecol 18: 840-843.
28. Ma C, Liu X, Ma Z (2009) Association between genetic polymorphism of GSTM1 and susceptibility to cervical cancer in Uighur women in Xinjiang. Chin J Obstet Gynecol 44: 629-631.
29. Nishino K, Sekine M, Kodama S, Sudo N, Aoki Y, et al. (2008) Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res 34: 994-1001.
30. Niwa Y, Hirose K, Nakanishi T, Nawa A, Kuzuya K, et al. (2005) Association of the MAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Janpanese subjects. Gynecol Oncol 96: 423-429. (Pubitemid 40127144)
31. Palma S, Novelli F, Padua L, Venuti A, Prignano G, et al. (2010) Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk. J Cancer Res Clin Oncol 136: 1101-9.
32. Settheetham-Ishida W, Yuenyao P, Kularbkaew C, Settheetham D, Ishida T (2009) Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Cancer Prev 10: 365-368.
33. Sharma A, Sharma JK, Murthy NS, Mitra AB (2004) Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma 51: 12-6. (Pubitemid 38250150)
34. Sierra-Torres CH, Au WW, Arrastia CD, Cajas-Salazar N, Robazetti SC, et al. (2003) Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environmental and Molecular Mutagenesis 41: 69-76. (Pubitemid 36159625)
35. Sierra-Torres CH, Arboleda-Morreno YY, Orejuela-Aristizabal L (2006) Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia, Environ Mol Mutagen 47: 553-561. (Pubitemid 44291168)
36. Singh H, Sachan R, Devi S, Pandey SN, Mittal B (2008) Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am J Obstet Gynecol 198: 303e301-306.
37. Sobti RC, Kaur S, Kaur P, Singh J, Gupta I, et al. (2006) Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet 166: 117-123.
38. Song GY, Song ZY, Xu JP, Shao SL (2008) Association of single nucleotide polymorphism in glutathione S-transferase-M1 with susceptibility to cervical cancer in Shanxi Province. Chinese Journal of Cancer Prevention and Treatment 15: 1054-1056.
39. Ueda M, Toji E, Nunobiki O, Izuma S, Okamoto Y, et al. (2008) Germline polymorphism of cancer susceptibility genes in gynecologic cancer. Human Cell 21: 95-104.
40. Zhou Q, Wang J, Shao S, Ma X, Ding L (2006) The association between glutathione S-transferase M1, T1 polymorphisms and risk of cervical cancer. Modern Preventive Medicine 33: 269-271.
41. Der Simonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7: 177-88. (Pubitemid 17189972)
42. Giuliano AR, Sedjo RL, Roe DJ, Harris R, Baldwin S, et al. (2002) Clearance of oncogenic human papilloma virus (HPV) infection: effect of smoking (United States). Cancer Causes Control 13: 839-46. (Pubitemid 35305203)
43. Jee SH, Lee JE, Kin S, Kim JH, Um SJ, et al. (2002) GSTP1 polymorphisms, cigarette smoking and cervical cancer risk in Korean women. Yonsei Med J 6: 712-6. (Pubitemid 36113784)
44. Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, et al. (2005) Active and passive cigarette smoking and risk of cervical neoplasia. Obstet Gynecol 105: 174-81. (Pubitemid 40189929)
45. Ying Liu, Liang-Zhi Xu (2012) Meta-analysis of association between GSTM1 gene polymorphism and cervical cancer. Asian Pacific Journal of Tropical Medicine 480-484.
46. Wacholder S, Silverman DT, Mclaughlin JK, Mandel JS (1992) Selection of controls in case-control studies II. Types of controls. Am J Epidemiol 135: 1029-41.